Literature DB >> 3404565

Rift Valley fever in Egypt 1986. Surveillance of sheep flocks grazing in the northeast Nile Delta.

B A Botros1, T G Ksiazek, J C Morrill, A W Salib, A K Soliman, R M Scott, A Barakat.   

Abstract

From October 1985 through November 1986, 1714 presumably unvaccinated sheep in 13 nomadic flocks located in four provinces in Dakahliya Governorate, in the northeast Nile Delta, were ear tagged and monitored for acquisition of Rift Valley fever virus (RVFV) antibodies. Sheep were bled at approximately 3 month intervals and sera were tested for haemagglutination inhibition (HI) antibodies to RVFV. HI reactors were tested for RVFV specific IgM antibody by enzyme-linked immunosorbent assay (ELISA) and neutralizing antibody to RVFV by plaque reduction neutralization (PRN) tests. Base line results showed 1.2% prevalence of HI antibody to RVFV with titres from 1:20 to 1:320. All HI positive sera were PRN positive through PRN titres were generally higher than HI titres. No RVFV specific IgM antibody was detected in the HI and PRN positive sera. Throughout the study, no initially seronegative sheep became positive and no HI positive sheep showed an appreciable increase above initial antibody titre. These data indicate absence of RVFV transmission to sheep in Dakahliya Governorate during the period of the study.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3404565

Source DB:  PubMed          Journal:  J Trop Med Hyg        ISSN: 0022-5304


  2 in total

1.  Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15.

Authors:  Claudia Mroz; Mayada Gwida; Maged El-Ashker; Mohamed El-Diasty; Mohamed El-Beskawy; Ute Ziegler; Martin Eiden; Martin H Groschup
Journal:  BMC Vet Res       Date:  2017-04-05       Impact factor: 2.741

Review 2.  Epidemiology of Mosquito-Borne Viruses in Egypt: A Systematic Review.

Authors:  Yuan Fang; Emad I M Khater; Jing-Bo Xue; Enas H S Ghallab; Yuan-Yuan Li; Tian-Ge Jiang; Shi-Zhu Li
Journal:  Viruses       Date:  2022-07-20       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.